Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
Muskan Gupta, Gurcharan Kaur
BMC Complementary and Alternative Medicine (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects
Subhabrata Paul, Shreya Chakraborty, Uttpal Anand, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112175-112175
Open Access | Times Cited: 180
Ashwagandha in brain disorders: A review of recent developments
Sultan Zahiruddin, Parakh Basist, Abida Parveen, et al.
Journal of Ethnopharmacology (2020) Vol. 257, pp. 112876-112876
Closed Access | Times Cited: 95
Neurodegenerative diseases and Withania somnifera (L.): An update
Nawab John Dar, MuzamilAhmad
Journal of Ethnopharmacology (2020) Vol. 256, pp. 112769-112769
Closed Access | Times Cited: 85
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
Akash Saggam, Kirti Limgaokar, Swapnil Borse, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 83
FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress
Kai Kang, Pengfei Xu, Mengxia Wang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110439-110439
Open Access | Times Cited: 79
Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of Nrf2/HO-1 and mitigation of NF-κB/MAPK signaling pathways
Heba M. A. Khalil, Hesham A. Eliwa, Riham A. El‐Shiekh, et al.
Journal of Ethnopharmacology (2021) Vol. 277, pp. 114141-114141
Closed Access | Times Cited: 62
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Anti-Neuroinflammatory Effects of Adaptogens: A Mini-Review
Dagmara Wróbel‐Biedrawa, Irma Podolak
Molecules (2024) Vol. 29, Iss. 4, pp. 866-866
Open Access | Times Cited: 11
Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood
Megan Leonard, Broderick Dickerson, Landry Estes, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1813-1813
Open Access | Times Cited: 10
Critical review of the Withania somnifera (L.) Dunal: ethnobotany, pharmacological efficacy, and commercialization significance in Africa
Henok Kessete Afewerky, Emmanuel Ayodeji Ayeni, Bashir B. Tiamiyu, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2021) Vol. 45, Iss. 1
Open Access | Times Cited: 42
Emerging Vistas for the Nutraceutical Withania somnifera in Inflammaging
Vivek Basudkar, Gunjan Gujrati, Saiprasad Ajgaonkar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 597-597
Open Access | Times Cited: 6
Ashwagandha (Withania somnifera) for the treatment and enhancement of mental and physical conditions: A systematic review of human trials
Adrian L. Lopresti, Stephen J. Smith
Journal of Herbal Medicine (2021) Vol. 28, pp. 100434-100434
Closed Access | Times Cited: 34
Withania somnifera - a magic plant targeting multiple pathways in cancer related inflammation
Praveen Kumar, Rohit Sharma, Neha Garg
Phytomedicine (2022) Vol. 101, pp. 154137-154137
Closed Access | Times Cited: 24
Role of nutraceuticals in cognition during aging and related disorders
Padmanabh Singh, Thamil Mani Sivanandam, Arpita Konar, et al.
Neurochemistry International (2020) Vol. 143, pp. 104928-104928
Closed Access | Times Cited: 32
Neuroprotective effect of Withania somnifera leaves extract nanoemulsion against penconazole-induced neurotoxicity in albino rats via modulating TGF-β1/Smad2 signaling pathway
Mohamed Abomosallam, Basma M. Hendam, Amr A. Abdallah, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1903-1928
Open Access | Times Cited: 4
Phytotherapy for treatment of cytokine storm in COVID­19
Leena Sapra, Asha Bhardwaj, Zaffar Azam, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 5, pp. 51-51
Open Access | Times Cited: 22
Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
Maria Deolinda Auxtero, Susana Chalante, Mário R. Abade, et al.
Pharmaceutics (2021) Vol. 13, Iss. 1, pp. 124-124
Open Access | Times Cited: 21
Network pharmacological evaluation of Withania somnifera bioactive phytochemicals for identifying novel potential inhibitors against neurodegenerative disorder
Sonu Pahal, Ayushi Gupta, Princy Choudhary, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 21, pp. 10887-10898
Open Access | Times Cited: 18
Biological and physical studies on the protective and therapeutic roles of ashwagandha seed extract against the potential toxic effect of amoxicillin in rats
Dalia Aboelhassan, Noha E. Ibrahim, Mohamed M. M. Elnasharty, et al.
Egyptian Pharmaceutical Journal (2024) Vol. 23, Iss. 2, pp. 251-263
Closed Access | Times Cited: 2
The role of nutraceutical fruit drink on neurodegenerative diseases: a review
Abiola Folakemi Olaniran, Abiola Ezekiel Taiwo, Oluwaseun Peter Bamidele, et al.
International Journal of Food Science & Technology (2021) Vol. 57, Iss. 3, pp. 1442-1450
Closed Access | Times Cited: 13
Sodium–calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer’s disease
Henok Kessete Afewerky, Hao Li, Tongmei Zhang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Protective effect of apple polyphenols on chronic ethanol exposure-induced neural injury in rats
Fang Wang, Jinghong Li, Lingxi Li, et al.
Chemico-Biological Interactions (2020) Vol. 326, pp. 109113-109113
Closed Access | Times Cited: 12
Integrated System Pharmacology and In Silico Analysis Elucidating Neuropharmacological Actions of Withania somnifera in the Treatment of Alzheimer’s Disease
Md. Abdul Hannan, Raju Dash, Md. Nazmul Haque, et al.
CNS & Neurological Disorders - Drug Targets (2020) Vol. 19, Iss. 7, pp. 541-556
Closed Access | Times Cited: 8
Therapeutic Effects of Withania somnifera: An Overview with Special Focus on Alzheimer’s Disease and Infertility among Youth
Deepika Saini, Mansi Srivastava, Sandhya Vaid, et al.
(2022), pp. 331-348
Closed Access | Times Cited: 5
Ginsenoside Rb1 attenuates lipopolysaccharide-induced chronic neuroinflammation in mice by tuning glial cell polarization
Yu‐Shu Liu, Juan Li, Xi Wang, et al.
Journal of Traditional Chinese Medical Sciences (2022) Vol. 9, Iss. 4, pp. 383-391
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top